Drug Trial Radar · NCT00680238
Pregnancy/Implantation Rates Using a Day 3 Score Versus Graduated Embryo Score Plus a Biochemical Marker (sHLA-G)
Last checked: Nov 20, 2026Latest source record: May 20, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
214
Actual
Start
Jun 2004
Primary completion
Jun 2007
Study completion Jun 2007
Sponsor
- Lead sponsor
- University of StellenboschAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 20, 2008
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Who can join
- Female only, from 25 years, up to 40 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Objective: To compare pregnancy rates and implantation rates when embryos are selected based on a single Day 3 (D.3) score vs. a GES score plus sHLA-G expression.
Conditions
- Infertility
Interventions
Human derived FSHDrug
Customized for each patient
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pregnancy and implantation ratesTime frame: 12 weeks
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.